Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma
Clinical trial NCT03251027 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03251027
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-17
- Primary completion
- 2027-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.